Petition Seeks OTC PPI Warning On Cancer Risk From Persistent Heartburn
This article was originally published in The Pink Sheet
Executive Summary
OTC proton pump inhibitors should carry a warning that the products do not eliminate risks of esophageal cancer from persistent heartburn, says the Esophageal Cancer Action Network in a citizen petition to US FDA. FDA should “immediately” require the warning, which should be bold and prominent.